Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs IVZ✓SelectedUSD · IVZGSK vs IVZ performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs IVZ

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
IVZ return
+116.9%
Excess return
-64.2%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioIVZExcessAlpha
1D-0.1%-4.5%+4.4%+0.1%
7D-5.3%-8.3%+3.0%-4.8%
30D-3.7%-8.7%+5.0%-3.2%
3M-7.3%-14.8%+7.6%-6.5%
6M-4.2%-0.3%-3.9%-4.4%
YTD+0.9%+4.0%-3.1%+0.1%
1Y+7.3%+20.3%-13.1%+5.6%
3Y+52.7%+114.9%-62.1%+42.8%
All+52.7%+116.9%-64.2%+42.8%

Cumulative growth

Daily Returns

Daily percentage return beside IVZ.

Daily Out/Under-Performance

Portfolio return minus IVZ return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × IVZ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded IVZ wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling